Scleroderma, systemic
Clinical trials for Scleroderma, systemic explained in plain language.
Never miss a new study
Get alerted when new Scleroderma, systemic trials appear
Sign up with your email to follow new studies for Scleroderma, systemic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell therapy takes on tough scleroderma
Disease control OngoingThis early trial tests whether a single infusion of anti-CD19 CAR T-cells can improve skin thickening and other symptoms in 6 adults with severe, treatment-resistant systemic sclerosis. Participants receive chemotherapy before the infusion and are monitored for 24 months. The stu…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase 2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug hope for scleroderma patients with lung complications
Disease control OngoingThis study tests an experimental drug called ifetroban in 34 adults with a severe form of scleroderma (diffuse cutaneous systemic sclerosis) or scleroderma-related lung disease (pulmonary arterial hypertension). The main goal is to see if the drug is safe and whether it can impro…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase 2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can light therapy loosen tight skin? new trial aims to find out
Symptom relief OngoingThis study tests whether 30 sessions of UVA-1 light therapy can improve daily life for people with scleroderma, morphea, or skin hardening from graft-versus-host disease. Thirty adults will report how their symptoms affect everyday tasks before and after treatment. The goal is to…
Matched conditions: SCLERODERMA, SYSTEMIC
Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC